THREAD
Schedule a Quick Demo
← Back

Accelerating Clinical Trials with No-Code: Faster Launches, Lower Costs, and True Study Flexibility

Clinical trials are becoming more complex, yet expectations around speed, cost, and patient experience continue to rise. Traditional approaches—reliant on custom builds, rigid systems, and lengthy timelines—create friction at every stage, from study startup to mid-study amendments.

A new model is emerging: one built on no-code configuration, reusable assets, and flexible study design. This approach removes operational bottlenecks, enabling teams to launch faster, adapt in real time, and support decentralized and hybrid trials without adding complexity.

See how it works in practice:

Enable Decentralized and Hybrid Trials—Without Added Complexity

No-code configuration makes it possible to design and execute decentralized and hybrid studies without relying on technical teams or custom development.

Flexible study design capabilities include:

  • Hybrid visit schedules combining site, remote, and virtual interactions
  • Event-driven or conditional visits based on patient activity or data
  • Remote-first participation models that reduce site dependency

This flexibility allows studies to be built around real patient behavior—improving accessibility, recruitment, and retention.

Operational flexibility extends beyond design. With built-in versioning and rollout capabilities, studies can evolve without disruption:

  • Protocol amendments can be implemented without rebuilding
  • Updates can be deployed across cohorts, regions, or sites seamlessly
  • New study arms can be introduced without restarting or delaying timelines

This ensures decentralized and hybrid trials remain adaptable while maintaining continuity and control.

Launch Faster and Adapt in Real Time

Eliminating custom builds dramatically accelerates study startup and reduces delays caused by rework.

Key advantages:

  • Faster time to First Patient In (FPI)
  • Rapid protocol adjustments without redevelopment
  • Parallel workflows across clinical and operational teams

The result is a more agile study model that keeps pace with evolving protocols and business priorities.

Reduce Costs Through Reuse, Standardization, and Integrated Technology

A library of 545+ pre-vetted eCOAs removes one of the most time- and cost-intensive steps in study setup.

With pre-built assessments, teams can:

  • Instantly deploy validated instruments
  • Reuse configurations across studies and programs
  • Standardize data collection without additional validation cycles

This leads to:

  • Lower build and validation costs
  • Reduced vendor reliance and fewer change orders
  • Greater operational efficiency across the portfolio

At the same time, a pre-integrated library of sensors, devices, and wearables eliminates another common source of delay and cost.

With one-click integration, teams can:

  • Add devices instantly without custom development
  • Combine objective and patient-reported data seamlessly
  • Deploy device-enabled studies without extending timelines

Together, reusable eCOAs and integrated technologies create a scalable foundation that reduces cost while increasing study capability.

Improve Patient Retention with Configurable Engagement

In decentralized and hybrid trials, consistent patient engagement is critical.

Built-in, configurable tools include:

  • Automated notifications and reminders for visits and assessments
  • Custom alerts tailored to protocol requirements
  • Flexible communication workflows aligned to study design

These capabilities help:

  • Increase adherence
  • Reduce dropout rates
  • Improve data completeness

The Bottom Line

No-code configuration is more than a usability improvement—it’s an operational advantage.

It enables:

  • Faster study launches
  • Lower overall costs
  • Flexible, patient-centric study designs
  • Scalable decentralized and hybrid trials

By removing technical barriers and enabling rapid configuration, organizations can move from protocol to execution faster—while delivering a better experience for both patients and study teams.